TechCrunch

OCTOBER 27, 2021

Protein biochemist Dr. Jasmin Hume was working in the alternative food space when she saw an opportunity to evolve technology so that our global food industry can reduce its reliance on animals. Both the food ingredients and plant-based proteins markets are poised for steady growth.

Biotech 206

Biotech Sustainability Industry Marketing 206

CIO

APRIL 17, 2024

Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on.

Software Review 324

Software Review Enterprise Generative AI Artificial Inteligence 324

TechCrunch

MARCH 17, 2023

Zero-based budgeting: A proven framework for extending runway 5 strategies for biotech startups to outlast a market downturn Image Credits: Getty Images Spinning up a biotech company is a massive undertaking.

Budget 230

Budget Biotech Artificial Inteligence Banking 230

CIO

MAY 15, 2024

The biotech company Moderna , for example, is aiming to use ChatGPT Enterprise to “automate nearly every business process” in order to “outpace its plan to roll out 15 new products within the next five years.” And with every passing day, “your guess is as good as mine” will become an increasingly uncomfortable answer.

Artificial Inteligence 325

Artificial Inteligence Generative AI Biotech Artificial Intelligence 325

Crunchbase News

MAY 2, 2024

April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generative AI markets. Let’s take a look.

Biotech 111

Biotech Generative AI Blockchain Energy 111

TechCrunch

MAY 4, 2022

.” A more favorable regulatory and social landscape is helping psychedelic startups gain a foothold, but they still have to walk a tightrope that’s susceptible to the vagaries of market sentiment. But as public market sentiment fluctuates, specialized VCs seem more likely to stick around for the whole trip. Ready for the trip?

Marketing 235

Marketing Biotech Technical Review Weak Development Team 235

TechCrunch

AUGUST 18, 2023

Clean tech – Tied in with the biotech trend, we’re seeing a continued surge in input/output companies that process waste to produce byproducts like energy and potable water. market is terrible at taking care of elderly and infirm people, in general. The robotics, AI and biotech sectors all play a part here.

Biotech 221

Biotech Technical Review Fintech Trends 221

Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. In fact, it only took raising about $30 million-plus to make the list.

Biotech 105

Biotech Generative AI Artificial Intelligence Artificial Inteligence 105

Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Celestial AI , $175M, semiconductors: Optical interconnectivity startup Celestial AI raised a massive $175 million Series C led by Thomas Tull ’s US Innovative Technology Fund.

Biotech 105

Biotech Artificial Intelligence Artificial Inteligence Energy 105

TechCrunch

MARCH 15, 2021

A new nanocoating from Curran Biotech could dramatically improve air filtration to prevent the spread of COVID-19 indoors. Their Capture Coating technology acts as a supplement to any household or commercial HVAC system by bonding to the filter fibers , giving them greater hydrophobic properties.

Biotech 257

Biotech Energy Recruiting Travel 257

TechCrunch

JANUARY 3, 2023

The competition is not your market competitor or incumbent. More often, it is the investor’s set of operating heuristics, many of which are quickly influenced by market conditions. When markets start to dip, most companies hunker down and focus on surviving. Reframe the macro view. Get granular.

Healthcare 214

Healthcare Marketing Games Analysis 214

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. The round was led by Thomas Tull ’s US Innovative Technology Fund. Freenome , $254M, biotech: This is just the first of many big biotech raises this week. That may not have happened since the early part of 2022 — if then.

Lambda 93

Lambda Biotech Artificial Intelligence Artificial Inteligence 93

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

TechCrunch

MAY 26, 2022

Ayeni has a similar function at Helios Digital Ventures: to spot and back disruptive startups in frontier markets, particularly in Africa and the Middle East. . What we’re trying to do from a strategy perspective is to say what sectors are large enough from an addressable market point of view and affect or impact the mass market.”.

Marketing 147

Marketing Biotech Fintech Banking 147

Crunchbase News

MAY 6, 2024

This has been particularly true for companies that took the SPAC route to public markets around the peak of the last boom. In response, a growing number are choosing to exit public markets and try their luck once again as private companies. After debuting on Nasdaq in 2021 at a $2.1 It didn’t go well.

Biotech 109

Biotech Case Study Marketing Study 109

TechCrunch

AUGUST 18, 2022

While we’re still far away from achieving that lofty goal, science has advanced a lot and as life expectancy increased, longevity is now a realm of technology and medicine that aims to increase how long people can live healthily. Analysts estimate that the market for delaying human death could be worth $610 billion by 2025.

Biotech 227

Biotech Survey Fintech Education 227

TechCrunch

FEBRUARY 10, 2022

Respira Labs , a medical technology company specializing in respiratory care, which first unveiled its product to the world last year , successfully raised $1 million in funding and an additional $1.8 million in grants to continue building its acoustic resonance technology to assess lung function and changes therein.

Biotech 199

Biotech Small Business Technology Leadership 199

TechCrunch

JANUARY 7, 2022

This morning private-market powerhouse Andreessen Horowitz announced that it has closed $9 billion in new capital for its venture capital, growth-stage and biotech-focused vehicles. As an investing collective, a16z, like many private-market investors, is putting more capital to work per new crop of new funds. remains red-hot.

Biotech 242

Biotech Groups Trends Marketing 242

TechCrunch

SEPTEMBER 28, 2021

Lifebit says it has a patented technology for federating the data around genomic data, allowing researchers to get more insights while keeping the data secure. In an increasingly hot biotech market, protecting IP is key. Privacy issues are regularly raised around genomic data.

Biotech 248

Biotech Data Government Research 248

Crunchbase News

MAY 7, 2024

The slowdown in venture funding has continued despite the AI technology wave that has washed over startups in the past few years. Top sectors Biotech and healthcare was the leading sector by funding amount in April. That is an increase over 2023, but still too few companies to suggest the public markets are truly opening.

Biotech 119

Biotech Generative AI Report Healthcare 119

TechCrunch

AUGUST 18, 2022

The hearing loss market has long been dominated by a handful of legacy players with little incentive to innovate due to outdated regulations and social stigma. Food and Drug Administration could revolutionize the market by driving competition, giving startups a greater chance at success in this sector. But a new ruling from the U.S.

Technical Review 240

Technical Review Innovation Technology Systems Review 240

TechCrunch

DECEMBER 8, 2020

UMI’s decision to invest in Boost comes from our evaluation of their team, technology, and the associated market opportunities. Boost is already working with an undisclosed biomanufacturing partner to develop its bio-fungicide. “These are critical areas to achieve food security and promote sustainable agriculture.

Biotech 168

Biotech Sustainability Applications Engineering 168

TechCrunch

AUGUST 29, 2022

Founded in 2019 by Dr. Abasi Ene-Obong, the three-year-old startup seeks to address the gap in the global genomics market where less than 3% of genetic material used in pharmaceutical research is African. Other operational and technology jobs were affected as well. Other companies include Swvl , Vezeeta , Wave , Sendy and Marketforce.

Testing 214

Testing Biotech Pharmaceuticals Insurance 214

TechCrunch

SEPTEMBER 14, 2021

Other fungicides on the market today require seven days before re-entry and pre-harvest, Uknes explained. His firm has an impact fund focused on the future of food and began investing in alternative proteins in 2016 before expanding that to delivery systems in agriculture technology, he said.

Technical Review 235

Technical Review Technology Chemicals Pharmaceuticals 235

TechCrunch

OCTOBER 25, 2022

Combining his experience as an operator and institutional investor, Abelson runs Irving as a multistrategy platform making long-term durable investments in both the public and private markets. Jacob Sonnenberg is a portfolio manager at Irving Investors and runs Irving's Technology and Consumer Crossover Fund. What am I worth now?

Blockchain 248

Blockchain Biotech .Net Marketing 248

TechCrunch

APRIL 21, 2022

As the global startup market digests a changing valuation environment and climate for venture investment, not every sector is taking the same amount of damage. Instead, it’s the tried-and-true software-as-a-service (SaaS) category that appears to be in the best shape to fend off a slowdown in private-market investment.

Biotech 251

Biotech Comparison Banking Marketing 251

TechCrunch

AUGUST 2, 2021

“We added fermentation/biotech technologies to enhance taste and texture,” wrote CEO and co-founder Christoph Jenny in an email to TechCrunch. The company plans to enter several new markets over Q3 and Q4, but the U.S. Over time the process has improved as well.

Biotech 255

Biotech Technical Review Travel Course 255

TechCrunch

MARCH 8, 2021

But Locus Biosciences is hoping that their crPhage technology might provide a new solution. Led in part by former Patheon executive and current Locus CEO Paul Garofolo, the startup launched in 2015 with the goal of using a less popular application of CRISPR technology to address growing antimicrobial resistance.

Technology 262

Technology Data Recruiting Research 262

TechCrunch

JULY 27, 2022

Biotech company Senzo just raised a $2 million round at a $20 million pre-money valuation to further extend options for lateral flow diagnostics. For starters, it’s hoping to bring a COVID-19 at-home rapid test through regulatory approval and then to market, but the company has a plethora of other tests up its proverbial sleeves.

Biotech 188

Biotech Testing Coaching Study 188

Crunchbase News

FEBRUARY 15, 2024

The venture market was down 38% last year as investors continued to reel back their funding with money becoming more expensive and liquidity options drying up. With its cash-intensive research and long product-to-market lead time, it usually is not attractive to investors in a down market where cash is king.

Biotech 95

Biotech Artificial Intelligence Artificial Inteligence Energy 95

TechCrunch

JULY 23, 2021

At TechCrunch Early Stage: Marketing and Fundraising, two experienced investors spoke on the subject and advised startups facing a challenging fundraising path. Pae Wu and Garrett Winther are both partners at SOSV and run the fund’s programs around biotech and hardware. Set obtainable goals.

Technical Advisors 254

Technical Advisors Biotech Hardware Applications 254

TechCrunch

DECEMBER 15, 2021

TechCrunch Battlefield (NYC 2014) finalists Mimi Hearing Technologies just closed its $25 million Series B funding to continue whispering its mission of hearing well-being from the rooftops. The company has made the same technology available to headphone manufacturers as an SDK. ” . ”

Biotech 223

Biotech Testing Technology Company 223

TechCrunch

APRIL 27, 2022

The crypto market is showing no signs of slowing down as funds and investors alike continue to deploy massive amounts of capital into the ecosystem. Also, the market has also grown so much. When we first started investing, the entire market for crypto was a few hundreds of billions and now it’s in the multitrillions.”.

Blockchain 241

Blockchain Biotech Software Engineering Games 241

TechCrunch

APRIL 3, 2023

“We seek out exceptional founding teams whose business plan is centered on the strategic utilization of technology to gain a competitive advantage. The technology sector has faced some short- to mid-term pressure globally due to recent market adjustments. We don’t limit ourselves to any specific sector,” Kazah said.

Technical Review 236

Technical Review Biotech Blockchain Fintech 236

TechCrunch

SEPTEMBER 17, 2021

Gingko’s market debut is one of the largest in biotech history. each this morning under the ticker DNA — biotech dieharders will recognize it as the former ticker used by Genentech. . I cannot predict when Roche might bring a drug to market and give me my milestones,” says Kelly. . It’s expected to raise about $1.6

Biotech 258

Biotech Sport Programming Company 258

TechCrunch

MAY 18, 2021

It is associated with The University of Tokyo (UTokyo), where it has a partnership with its Technology Licensing Office (TLO) to spin off and invest in companies that originated as research projects. Broadly speaking, UTEC focuses on three areas: healthcare and life sciences, information technology and physical sciences and engineering.

Biotech 249

Biotech Automotive Research Healthcare 249

TechCrunch

OCTOBER 6, 2022

France could become a leading market when it comes to sustainability-focused and impact startups due to local and European regulation, innovation and talent looking for opportunities in this ecosystem. But impact companies could still benefit from new processes, better network effects and more ambition in general.

Sustainability 188

Sustainability Programming Technical Review Biotech 188